News
Despite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results